BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14629827)

  • 1. The multidrug resistance of in vitro tumor cell lines derived from human breast carcinoma MCF-7 does not influence pentavalent technetium-99m-dimercaptosuccinic Acid uptake.
    Denoyer D; Perek N; Le Jeune N; Frère D; Dubois F
    Cancer Biother Radiopharm; 2003 Oct; 18(5):791-801. PubMed ID: 14629827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptake.
    Perek N; Le Jeune N; Denoyer D; Dubois F
    Cancer Biother Radiopharm; 2005 Aug; 20(4):391-400. PubMed ID: 16114987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells.
    Le Jeune N; Perek N; Denoyer D; Dubois F
    Cancer Biother Radiopharm; 2005 Jun; 20(3):249-59. PubMed ID: 15989470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
    Papantoniou VJ; Souvatzoglou MA; Valotassiou VJ; Louvrou AN; Ambela C; Koutsikos J; Lazaris D; Christodoulidou JK; Sotiropoulou MG; Melissinou MJ; Perperoglou A; Tsiouris S; Zerva CJ
    Breast Cancer Res; 2004; 6(2):R56-62. PubMed ID: 14979918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of glutathione depletion on plasma membrane cholesterol esterification and on Tc-99m-sestamibi and Tc-99m-tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug-resistant MRP1 human glioma cells.
    Le Jeune N; Perek N; Denoyer D; Dubois F
    Cancer Biother Radiopharm; 2004 Aug; 19(4):411-21. PubMed ID: 15453956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the multidrug resistance of glioma by glutathione levels depletion--interaction with Tc-99M-Sestamibi and Tc-99M-Tetrofosmin.
    Perek N; Koumanov F; Denoyer D; Boudard D; Dubois F
    Cancer Biother Radiopharm; 2002 Jun; 17(3):291-302. PubMed ID: 12136521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
    Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
    J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
    Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
    Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF
    Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
    Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
    Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines.
    Denoyer D; Perek N; Le Jeune N; Frere D; Dubois F
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):77-84. PubMed ID: 14557898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
    Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
    J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc-99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression.
    Chang CS; Yang SS; Yeh HZ; Kao CH; Chen GH
    Hepatogastroenterology; 2004; 51(55):211-4. PubMed ID: 15011866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
    Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C
    Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.
    Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Peters AM
    Acta Oncol; 2004; 43(5):443-52. PubMed ID: 15360048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance.
    Kabasakal L; Ozker K; Hayward M; Akansel G; Griffith O; Isitman AT; Hellman R; Collier D
    Eur J Nucl Med; 1996 May; 23(5):568-70. PubMed ID: 8698063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of drug transporters involved in the urinary secretion of [
    Kobayashi M; Mizutani A; Okamoto T; Muranaka Y; Nishi K; Nishii R; Shikano N; Nakanishi T; Tamai I; Kleinerman ES; Kawai K
    Nucl Med Biol; 2021; 94-95():92-97. PubMed ID: 33609918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (99m)Tc-MIBI imaging for prediction of therapeutic effects of second-generation MDR1 inhibitors in malignant brain tumors.
    Sasajima T; Shimada N; Naitoh Y; Takahashi M; Hu Y; Satoh T; Mizoi K
    Int J Cancer; 2007 Dec; 121(12):2637-45. PubMed ID: 17708555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
    Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
    J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.